Drawing for IMMUNITAIRE

USPTO serial 97166606

IMMUNITAIRE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
TOMLINSON, SABRINA R
Law office
TMO LAW OFFICE 112 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with IMMUNITAIRE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. Leonard

Michael J. Leonard FOX ROTHSCHILD LLP997 LENOX DRIVE, BLDG. 3LAWRENCEVILLE, NJ 08648-2311UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals and pharmaceutical preparations, namely, anti-inflammatories ANTI-Fibrotic properties; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, hyperlipidemia, insulin resistance, metabolic syndrome , the endocrine system, namely growth and thyroid disorders, the musculo-skeletal system and the genitourinary system, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of skin disorders namely dermatitis, skin pigmentation diseases, eczema and psoriasis; pharmaceutical products for the prevention and treatment of respiratory diseases including bronchiolitis obliterans and idiopathic pulmonary fibrosisACTIVE—
042Pharmaceutical research and development services; research and development of vaccines and medicines; scientific and technological services, namely, scientific research, analysis, and testing services in the fields of drug development, biotechnology, microbiology and molecular biologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jul 18, 2023MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 18, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 18, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 22, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 17, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 17, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 21, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 21, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 21, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 19, 2022DOCKASSIGNED TO EXAMINER—
Jan 20, 2022AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jan 20, 2022ALIEASSIGNED TO LIE—
Jan 16, 2022PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Dec 15, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 14, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance